IQVIA Holdings | IQV - Operating Expenses


IQVIA Holdings reported $6.22B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Accenture USD 15.54B 7.67M Mar/2026
Agilent USD 1.44B 9M Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Cardinal Health USD -2.83B 52M Mar/2026
Celltrion KRW 140.68B 584.31B Dec/2025
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cigna USD 42.21B 497.12M Mar/2026
Cognizant Technology Solutions USD 15.07B 10.59B Mar/2026
Computer Programs Systems USD 207.2M 119.28M Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
CVS Health USD 95.75B 7.84B Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Divis Laboratories Ltd INR 20.17B 1.85B Mar/2026
Elevance Health USD 43.9B 5.26B Mar/2026
Humana USD 37.89B 4.57B Mar/2026
IBM USD 32.97B 17.54B Mar/2026
Illumina USD 852M 51M Mar/2026
Infosys INR 370.7B 366.69B Dec/2025
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.13B 6.3M Mar/2026
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 94.46B 10.04B Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Organigram Holdings CAD 83.66M 24.44M Dec/2025
Ovoca Bio EUR 1.16M 4.48M Jun/2025
Pharma Mar EUR 42.28M 4.59M Mar/2026
Publicis EUR 7.53B 244M Dec/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Sartorius EUR 738.4M 22.4M Mar/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Tilray USD 237.52M 17.34M Sep/2025
UnitedHealth USD 102.68B 7.27B Mar/2026
Veeva Systems USD 609.84M 19.76M Mar/2026
Veradigm USD 188M 61.08M Dec/2022
Waters USD 1.12B 457.15M Mar/2026
Zealand Pharma A/S 775.97M 265.08M Dec/2025
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026